A detailed history of Continuum Advisory, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Continuum Advisory, LLC holds 328 shares of TEVA stock, worth $5,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
328
Previous 245 33.88%
Holding current value
$5,740
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$12.78 - $17.4 $1,060 - $1,444
83 Added 33.88%
328 $5,000
Q1 2024

May 10, 2024

BUY
$10.67 - $14.43 $2,614 - $3,535
245 New
245 $3,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.